-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Lifecore Biomedical, Inc. \De\ quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2009 to 2023.
- Lifecore Biomedical, Inc. \De\ Weighted Average Number of Shares Outstanding, Diluted for the quarter ending August 25, 2024 was 30.9M shares, a 1.49% increase year-over-year.
- Lifecore Biomedical, Inc. \De\ annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 36.7M shares, a 22.4% increase from 2022.
- Lifecore Biomedical, Inc. \De\ annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 30M shares, a 1.67% increase from 2021.
- Lifecore Biomedical, Inc. \De\ annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 29.5M shares, a 0.59% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)